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Abstract
Objective: To determine whether visceral adipose tissue or 
serum RBP-4 were related to the risk increment of insulin 
resistance in normal BMI PCOS patients.
Methods: This was a cross-sectional study conducted in 
normal body mass index PCOS patients at Yasmin Clinic, 
RSCM, Jakarta from July 2014 until March 2015. Diagnosis 
of PCOS was established using Rotterrdam (2003) criteria. 
Insulin resistance was confi rmed by using ratio of HOMA-IR 
>1.4. 
Results: Among 40 subjects, 20 subjects (50%) belong 
insulin resistance group. Serum RBP-4 level was higher in 
the insulin-resistant group (p=0.06). After ROC analysis was 
conducted, the area under curve for serum RBP-4 was 69.9% 
(CI 95% -3754.77 - (186.60-7696.14, p=0.061)). The cut-off 
level of serum RBP-4 was 23814.5 ng/mL yielded sensitivity 
and specifi city to a level of 60% and 60%, respectively. 
After logistic regression was analyzed, visceral adipose 
tissue demonstrated substantial association with the risk 
increment of insulin resistance in normal BMI PCOS patients. 
Conclusions: Visceral adipose tissue demonstrated 
substantial association with the risk increment of insulin 
resistance in normal BMI PCOS patients, independent with 
serum RBP-4 levels.
Keywords: body mass index, diagnosis, insulin resistance, 
PCOS, retinol-binding protein-4.
Abstrak
Tujuan: Untuk menentukan apakah jaringan adiposa viseral 
atau serum RBP-4 berhubungan dengan peningkatan risiko 
resistensi insulin pada Sindrom Ovarium Polikistik dengan 
indeks masa tubuh normal.
Metode: Studi potong lintang dilakukan pada subjek SOPK 
dengan IMT normal di Klinik Yasmin, RSCM, Jakarta sejak 
Juli 2014 sampai dengan Maret 2015. Penegakan diagnosis 
SOPK dilakukan dengan kriteria Rotterdam (2003). Resistensi 
insulin dikonfi rmasi dengan pemeriksaan rasio HOMA-IR > 
1.4
Hasil: Diantara 40 subjek, sebanyak 20 subjek (50%) 
mengalami resistensi insulin. Kadar serum RBP-4 lebih tinggi 
pada kelompok resistensi insulin (p=0.06). Setelah dilakukan 
analisis Receiver Operating Curve (ROC), serum RBP-4 
memiliki Area Under the Curve  (AUC) sebesar 69.9% (IK 95% 
-3754.77 - (186.60-7696.14, p=0,061)). Titik potong kadar 
serum RBP-4 adalah 23814.5 ng/mL dengan sensitivitas dan 
spesifi sitas masing-masing 60% dan 60%. Setelah dilakukan 
analisis regresi logistik, jaringan adiposa viseral menunjukan 
asosiasi yang kuat dengan terjadinya resistensi insulin pada 
pasien SOPK dengan IMT normal.
Kesimpulan: Jaringan adiposa viseral menunjukan asosiasi 
yang kuat dengan terjadinya resistensi insulin pada SOPK 
dengan IMT normal, independen terhadap kadar serum 
RBP-4. 
Kata kunci: diagnosis, indeks masa tubuh, resistensi insulin, 
retinol binding protein-4, SOPK.
INTRODUCTION
Polycystic Ovarian Syndrome is a frequent 
endocrine disorder in women on their 
reproductive period, affecting 4-18% of these 
population using Rotterdam criteria.1 Insulin 
resistance, hyperandrogenism, and gonadotropin 
axis disorder were considered to be a key for 
PCOS pathophysiology. Insulin resistance is 
also attributed to the development of later 
complications, e.g. metabolic syndrome, type-2 
diabetes mellitus, and cardiovascular disease2,3 
Fat also contributes to the pathophysiology of 
PCOS. It is also supported by other studies that 
most of the PCOS patient had excess body fat 
level, even though several patients still had normal 
body fat level based on BMI calculation.4,5 An 
excess fat tissue can be an etiologic factor in the 
pathogenesis of low-grade chronic infl ammation 
in PCOS. 6 The hypertrophied accumulated fat 
tissue can cause decreased blood perfusion and 
end up with fat tissue hypoxia. Apoptosis process 
may follow the fat hypoxia that causes a higher 
macrophage cell infi ltration and enhance the 
secretion of proinfl ammatory cytokines from 
adipose tissue. 
Low-grade chronic infl ammation can be 
expressed if there is an enhancement in cytokines 
productions such as CRP, TNFα, procalcitonin 
and interleukin-6, associated with the body’s 
immune response mechanism. TNFα and IL-6 
as pro-infl ammatory cytokines can induce 
phosphorylation of serine residues on insulin 
receptor substrate-1, which can lead to insulin 
resistance.7 
Several factors can be used in PCOS patient in 
determining body fat levels such as body mass 
index, waist to hip ratio and waist circumference, 
but for those patient who had normal or 
underweight posture, those measurement will be 
within normal limit. Whereas from the previous 
studies reported that insulin resistance may also 
be found either in obese or in non-obese PCOS 
patients. Among those with non-obese PCOS 
patients showing waist circumference less than 
80 cm, the prevalence of insulin resistance was 
observed in 30-50% of population. In addition, 
using CT scan, normal BMI PCOS patients showed 
a signifi cantly higher percentage of visceral 
adipose tissue.8-10
 Visceral adipose tissue plays a central role in 
pathophysiology related to PCOS compared to 
subcutaneous adipose tissue. A previous study 
on a mouse model for PCOS showed structural 
changes in adipose tissue that play an important 
role in the pathophysiology of insulin resistance 
in PCOS.  CT scan and MRI were considered gold 
standards for adipose tissue estimation.4,11-12 
Visceral adipose tissue secretes adipocytokines 
and adiponectin which are related to insulin 
resistance. Adipocytokines produces several 
hormones, one of them is retinol-binding protein 
4 (RBP-4).13-16 RBP-4 might be a suitable marker 
that signals the presence of early insulin resistance 
and may contribute to the pathophysiology 
of insulin resistance, by affecting hepatic 
gluconeogenesis and disturbing the mechanism 
of the insulin signalling system in muscles and also 
halts glucose uptake. Besides, RBP-4 is a gender 
specifi c marker that higher in women. RBP-4 level 
is raised before diabetes occurred.8,10,16-20 
Previous studies found confl icting results 
regarding the association of RBP-4 serum 
level with insulin resistance among PCOS 
patients.3,15,19,21 Interestingly, another studies 
found a signifi cant positive correlation of RBP-
4 level and visceral adipose tissue percentage 
measured by CT scan or MRI.13,22-24 Thus, this 
research is purposed to know the accuracy and 
cut-off point of RBP-4 level among our patients 
to decide whether serum RBP-4 might be a 
suitable marker for insulin resisance among PCOS 
patients with normal body mass index. 
METHODS
This was a cross-sectional study conducted 
at Yasmin Clinic, RSCM, Jakarta from July 2014 
until March 2015. Subjects were recruited 
consecutively. The inclusion criteria applied in this 
study were patients aged 18-40 years old following 
Rotterdam 2003 citeria for PCOS diagnosis. 
PCOS is considered when two or more criteria 
fulfi lled (oligo/anovulation, hyperandrogenism, 
and appearance of polycystic ovarian based on 
ultrasonography), and body mass index 18.5-
24.9 Kg/m2. Patients with infertility from patients' 
history, hyperprolactinemia, confi rmed type-
2 diabetes mellitus, and already in ovulation 
induction agents, previous glucocorticoid 
medication, oral hypoglycemic agents, and 
insulin during the last three months at the time 
of data collection were excluded.
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We measured the body mass index and waist 
circumference. Ten ml blood samples from fossa 
cubity vein were collected for fasting plasma 
glucose, fasting insulin level, and serum RBP-
4 level measurements. Laboratory tests were 
conducted at Prodia® laboratory, Jakarta. RBP-
4 level was determined using ELISA method 
(Quantikine Human RBP4 Immunoassay). Insulin 
resistance is determined by HOMA-IR >1.4 based 
on a previous study of the Chinese population. 
25,26
All numerical data were tested for its normality 
using the Shapiro-Wilk test. Normally distributed 
data presented as mean ± standard deviation, 
otherwise, the data were presented as median 
(minimum-maximum). For diagnostic analysis, 
we determined the cut-off point of RBP-4 using 
statistical analysis for the best possible sensitivity 
and specifi city. Categorical and numerical data 
bivariate analysis among insulin resistance and 
non-insulin resistance were performed using chi-
square test and independent t-test, respectively. 
Variables with initial p-value <0.25 were included 
in multivariate analysis using logistic regression 
with backward LR method to eliminate 
insignifi cant variables. ROC was applied to 
estimate the area under the curve (AUC). P-value 
<0.05 was considered signifi cant. We performed 
statistical analysis using SPSS (statistical package 
for Social Science, Chicago, Inc) for windows 
version 20.
All subjects had signed informed consent form 
before included in this study. The study protocol 
was approved by ethical committee Faculty 
of Medicine, Universitas Indonesia, Jakarta, 
Indonesia (form No. 498/H2.F1/ ETIK/2014).
RESULTS
A total of 40 subjects were recruited during 
this study period. 20 subjects (50%) were 
confi rmed having insulin resistance. The mean 
age of subjects was 27,43 ± 4,13 years old with 
mean body mass index was 22.02 ± 1.81 kg/m2. 
Characteristics of subjects were presented in table 
1. Insulin resistance subjects were signifi cantly 
older, had higher BMI, waist circumference, RBP-
4 level and percentage of visceral adipose tissue. 
Among subjects with insulin resistance, RBP-
4 level was higher than non-insulin resistance 
group (26862.93 ± 6728.69 ng/ml and 23108.16 
± 3630.43 ng/ml, p=0.061). The area under the 
curve for RBP-4 measurement was 0.669.  Using 
23814.5 ng/mL as a cut-off point, RBP-4 level had 
60% sensitivity and 60% specifi city. 
Table 1. Characteristics of Subjects
Characteristics All subjects
N=40 (%)
Insulin resistance
N=20 (%)
Non-insulin 
resistance
N=20 (%)
Mean difference
 (95% CI)
P-value
Age (years)
BMI (Kg/m2)
Waist 
circumference (cm)
RBP-4 (ng/ml)
Total body fat
Normal
Excessive
Visceral adipose 
tissue
Normal
Excessive
27,43 ± 4,13
22.02 ± 1.81
79.6 ± 6.66
23867.5 (19013-42623)
23 (57.5)
17 (42.5)
32 (80.0)
8 (20.0)
26.32 ± 4.04
21.43 ± 1.71
77.92 ± 6.57
23108.16 ± 3630.43
13 (56.52)
7 (41.18)
20 (62.5)
0 (0)
0.03
0.006
0.038
0.061
0.934
<0.001
-2.95 -(0.36- 5.54)
-1.59 -(.45-2.68)
-4.48 - (.269-8.69)
-3754.77 -(186.60-7696.14)
29.27 ± 3.69
23.02 ± 1.56
82.4 ± 5.60
26862.93 ± 6728.69
10 (43.48)
10 (58.82)
12 (37.5)
8 (100)
Age, waist circumference, BMI, and visceral 
adipose tissue were then included in multivariate 
analysis. Only age and visceral adipose tissue 
suited to the fi nal multivariate model (Table 2). 
The risk of insulin resistance were evaluated 
with ROC curve with AUC 0.669 (CI 95%; 0.487 – 
0.852, P-value 0.076) while visceral adipose tissue 
demonstrated higher AUC level 0.89 (Ci 95%; 
0.647 –  0.956, P-value: 0.002, fi gure 1). 
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accuracy for metabolic syndrome among PCOS 
patients was only 66%.[15] In our study, 23814.5 
ng/mL as a cut-off point of RBP-4 had moderate 
level of sensitivity and specifi city as a marker 
for insulin resistance (60% sensitivity and 60% 
specifi city).14,22,23 
Our study found that RBP-4 levels in lean 
PCOS patients did not show any association with 
insulin resistance, this result was similar with 
previous study, showed higher RBP-4 levels in 
subjects with metabolic syndrome, obesity and 
impaired glucose metabolism. 3,19,21,32,33
Known that RBP-4 synthesis not only in visceral 
adipose tissue but also in all adipose tissue and 
mostly in the hepatic tissue, it can be the cause no 
association between RBP-4 and insulin resistance 
in normal BMI PCOS patient. 34,35
Worth to note that from previous study, 
quantitative measurement of visceral adipose 
tissue using Bioelectric Impedance Analysis as 
applied in this study, eventhough in this research 
visceral fat measurement has not been using 
gold standard examination but the AUC yielded 
71.8% sensitivity  and 93.8% specifi city.3,19,21,33,36 
DISCUSSION
We confi rmed 20 out of 40 PCOS patients 
with normal body mass index (50%) were insulin 
resistance. This fi nding was in agreement with 
previous studies. They observed that 25% of 
PCOS patients belonged to normal body mass 
index and about a half of them had insulin 
resistance. In addition, 30-50% PCOS patient with 
waist circumference less than 80 cm were insulin 
resistance.8,9,27,28 The mean level of RBP-4 in this 
study was 23867.5ng/mL. Insulin resistance group 
showed a higher level of RBP-4 compared to the 
non-insulin resistance group, similar to previous 
studies. 8,15,29 
 Insulin resistance was considered important 
pathophysiology of PCOS. It was estimated 
that half of the PCOS patients had impaired 
insulin signalling in the target tissues. The 
mechanism of insulin resistance was described, 
which observed a down-regulation of glucose 
transport in inuslin signaling process and 
decline in serine autophosphorilase in insulin 
receptors.30,31 Identifi ed among pregnant women, 
RBP-4 level ≥ 42 ng/ml could predict gestasional 
diabetes mellitus with 75.8% sensitivity and 
63.5% specifi city. Found that RBP-4 level could 
estimate metabolic syndrome. However, its 
This fi gure showed ROC between RBP-4 and 
Visceral adipose tissue with the incidence of 
insulin resistance in lean PCOS, with AUC 
Figure 1. Receiver operating curve of RBP-4 level, 
Visceral adipose and  Insulin Resistance
Table 2. Multivariate Analysis to Calculate the Risk of Insulin Resistance
Variables B S.E. Wald df P-value Exp (B) 95% CI
Age
Visceral 
adipose tissue
Constant
0.224
0.392
-9.434
0.113
0.133
3.588
3.936
8.674
6.914
0.047
0.003
0.009
1.252
1.479
0
1.003
1.14
1.562
1.92
1
1
1
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CONCLUSION
We conclude that RBP-4 level was higher in 
insulin resistance group among PCOS patients 
with normal BMI even though it can not be used 
as a marker for visceral adipose tissue. Visceral 
adipose tissue can be used as a marker for 
insulin resistance in lean PCOS with AUC 0.801 
with 66.7% sensitivity and 80% specifi city. The 
optimum cut off point was 5.5 based on this study. 
Waist circumference examination can be used 
as a predictor in determining insulin resistance 
in lean PCOS patient and do not need further 
sophisticated examination. Further investigation 
is needed due to variations of protein present 
which will be potential to be assessed as insulin 
resistance marker in PCOS patients. 
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